STAAR Surgical to Present at the 9th Annual Needham & Company, LLC Growth Conference
MONROVIA, Calif., Jan. 5 /PRNewswire-FirstCall/ -- STAAR Surgical Company (Nasdaq: STAA), a leading developer, manufacturer and marketer of minimally invasive ophthalmic products, today announced that it will present at the 9th Annual Needham & Company, LLC Growth Conference, which will take place at the Palace Hotel in New York City. The Company is scheduled to discuss its business strategy and historical financial performance on Thursday, January 11, 2007, at 2:30 p.m. Eastern Time.
Attendance at the conference is by invitation only. A live audio webcast of STAAR's presentation may be accessed through the Company's website at www.staar.com. An archived replay of the presentation will be available after the live presentation and can also be accessed at www.staar.com for 90 days.
About STAAR Surgical
STAAR Surgical is a leader in the development, manufacture and marketing
of minimally invasive ophthalmic products employing proprietary technologies.
STAAR's products are used by ophthalmic surgeons and include the Visian ICL, a
tiny, flexible lens implanted to correct refractive errors, as well as
innovative products designed to improve patient outcomes for cataracts and
glaucoma. STAAR's ICL is approved by the FDA for use in treating myopia, has
received CE Marking and is approved for sale in 43 countries. More than
65,000 ICLs have been sold worldwide. More information is available at
www.staar.com.
CONTACT: Investors Media
EVC Group EVC Group
Douglas Sherk, 415-896-6820 Jen Saunders, 646-201-5341
Jennifer Beugelmans, 646-201-5445
SOURCE STAAR Surgical Company
-0- 01/05/2007
/CONTACT: media, Jen Saunders, +1-646-201-5431, or investors, Douglas
Sherk, +1-415-896-6820, or Jennifer Beugelmans, +1-646-201-5445 all of EVC
Group, for STAAR Surgical/
/Web site: http://www.staar.com/
(STAA)
CO: STAAR Surgical Company
ST: California, New York
IN: HEA MTC
SU: TDS CCA
SF-CD
-- SFF039 --
3506 01/05/2007 16:00 EST http://www.prnewswire.com